We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-4.05%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.11B
AUM Growth
-$170M
Cap. Flow
-$54.7M
Cap. Flow %
-2.59%
Top 10 Hldgs %
25.5%
Holding
2,409
New
42
Increased
215
Reduced
756
Closed
94

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.75M
2
TSLA icon
Tesla
TSLA
+$1.84M
3
CSGP icon
CoStar Group
CSGP
+$1.61M
4
PCG icon
PG&E
PCG
+$1.12M
5
EQT icon
EQT Corp
EQT
+$955K

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Healthcare 13.97%
3 Financials 12.12%
4 Consumer Discretionary 10.21%
5 Industrials 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KAI icon
926
Kadant
KAI
$3.94B
$119K 0.01%
711
FORM icon
927
FormFactor
FORM
$10.1B
$119K 0.01%
4,732
WAFD icon
928
WaFd
WAFD
$2.79B
$119K 0.01%
3,953
KWR icon
929
Quaker Houghton
KWR
$2.95B
$118K 0.01%
820
ESGR
930
DELISTED
Enstar Group
ESGR
$118K 0.01%
696
OI icon
931
O-I Glass
OI
$1.04B
$118K 0.01%
9,092
WSBC icon
932
WesBanco
WSBC
$4.07B
$118K 0.01%
3,528
SYBT icon
933
Stock Yards Bancorp
SYBT
$2.64B
$118K 0.01%
1,731
ACAD icon
934
Acadia Pharmaceuticals
ACAD
$5.07B
$117K 0.01%
7,155
-629
-8% -$10.2K
JJSF icon
935
J&J Snack Foods
JJSF
$1.67B
$117K 0.01%
902
RVNC
936
DELISTED
Revance Therapeutics, Inc.
RVNC
$117K 0.01%
4,315
-459
-10% -$9.31K
PRKS icon
937
United Parks & Resorts
PRKS
$2.01B
$115K 0.01%
2,527
-208
-8% -$10.4K
KTB icon
938
Kontoor Brands
KTB
$4.51B
$115K 0.01%
3,412
ESE icon
939
ESCO Technologies
ESE
$7.78B
$115K 0.01%
1,561
ABR icon
940
Arbor Realty Trust
ABR
$974M
$114K 0.01%
9,949
+951
+11% +$14K
AX icon
941
Axos Financial
AX
$5.68B
$114K 0.01%
3,341
-282
-8% -$11.4K
VISN
942
Vistance Networks Inc
VISN
$2.67B
$114K 0.01%
12,398
APPF icon
943
AppFolio
APPF
$6.97B
$114K 0.01%
1,090
-113
-9% -$11.5K
PRGS icon
944
Progress Software
PRGS
$1.79B
$114K 0.01%
2,682
ITRI icon
945
Itron
ITRI
$4.49B
$113K 0.01%
2,691
BMBL icon
946
Bumble
BMBL
$344M
$113K 0.01%
5,262
RUSHA icon
947
Rush Enterprises Class A
RUSHA
$9.41B
$113K 0.01%
3,860
EPC icon
948
Edgewell Personal Care
EPC
$1.32B
$113K 0.01%
3,012
-307
-9% -$12K
SMTC icon
949
Semtech
SMTC
$12.4B
$112K 0.01%
3,816
FATE icon
950
Fate Therapeutics
FATE
$294M
$111K 0.01%
4,972

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2022 Portfolio in Review

As of Q3 2022, Metropolitan Life Insurance Company (MetLife) held 2,409 positions worth $2.11B, down 7.5% from $2.28B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2022 filing shows 42 new, 215 increased, 756 reduced and 94 closed positions. Its largest new stake was CoStar Group: 23,153 shares worth $1.61M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $11.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2022 buy was CoStar Group: 23,153 shares worth $1.61M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares MSCI EAFE ETF in Q3 2022, an estimated $3.75M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $11.4M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Healthcare Realty Trust Incorporated in Q3 2022, selling an estimated $433K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $2.11B portfolio in Q3 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 42 new positions and closed 94 in Q3 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 7.5% quarter-over-quarter to $2.11B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.